Literature DB >> 1717254

Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure.

A Wright1, M H Tao, E A Kabat, S L Morrison.   

Abstract

The presence of N-linked carbohydrate at Asn58 in the VH of the antigen binding site of an antibody specific for alpha(1----6)dextran (TKC3.2.2) increases its affinity for dextran 10- to 50-fold. Site-directed mutagenesis has now been used to create novel carbohydrate addition sequences in the CDR2 of a non-glycosylated anti-dextran at Asn54 (TST2) and Asn60 (TSU7). These antibodies are glycosylated and the carbohydrates are accessible for lectin binding. The amino acid change in TSU7 (Lys62----Thr62) decreases the affinity for antigen; however, glycosylation of TSU7 increased its affinity for antigen 3-fold, less than the greater than 10-fold increase in affinity seen for glycosylated TKC3.2.2. The difference in impact of glycosylation could result either from the position of the carbohydrate or from its structure; unlike the other antibodies, TSU7 attaches a high mannose, rather than complex, carbohydrate in CDR2. In contrast, glycosylation of TST2 at amino acid 54 inhibits dextran binding. Thus slight changes in the position of the N-linked carbohydrate in the CDR2 of this antibody result in substantially different effects on antigen binding. Unlike what was observed for the anti-dextrans, a carbohydrate addition site placed in a similar position in an anti-dansyl is not utilized.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717254      PMCID: PMC452979          DOI: 10.1002/j.1460-2075.1991.tb07819.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  29 in total

Review 1.  Conformations of immunoglobulin hypervariable regions.

Authors:  C Chothia; A M Lesk; A Tramontano; M Levitt; S J Smith-Gill; G Air; S Sheriff; E A Padlan; D Davies; W R Tulip
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

Review 2.  Three-dimensional structure of antibodies.

Authors:  P M Alzari; M B Lascombe; R J Poljak
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

3.  Model-building study of the combining sites of two antibodies to alpha (1----6)dextran.

Authors:  E A Padlan; E A Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Production and properties of chimeric antibody molecules.

Authors:  S U Shin; S L Morrison
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

5.  Complete amino acid sequence and structure characterization of the taste-modifying protein, miraculin.

Authors:  S Theerasilp; H Hitotsuya; S Nakajo; K Nakaya; Y Nakamura; Y Kurihara
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

Review 6.  Assembly of asparagine-linked oligosaccharides.

Authors:  R Kornfeld; S Kornfeld
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

7.  Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.

Authors:  M H Tao; S L Morrison
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

8.  Different VL and VH germ-line genes are used to produce similar combining sites with specificity for alpha(1----6)dextrans.

Authors:  P N Akolkar; S K Sikder; S B Bhattacharya; J Liao; F Gruezo; S L Morrison; E A Kabat
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

9.  Tissue-specific N-glycosylation, site-specific oligosaccharide patterns and lentil lectin recognition of rat Thy-1.

Authors:  R B Parekh; A G Tse; R A Dwek; A F Williams; T W Rademacher
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

10.  Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen.

Authors:  S C Wallick; E A Kabat; S L Morrison
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  33 in total

1.  Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges.

Authors:  Yulia Vugmeyster; Xin Xu; Frank-Peter Theil; Leslie A Khawli; Michael W Leach
Journal:  World J Biol Chem       Date:  2012-04-26

Review 2.  Modulating carbohydrate-protein interactions through glycoengineering of monoclonal antibodies to impact cancer physiology.

Authors:  Austin Wt Chiang; Shangzhong Li; Philipp N Spahn; Anne Richelle; Chih-Chung Kuo; Mojtaba Samoudi; Nathan E Lewis
Journal:  Curr Opin Struct Biol       Date:  2016-09-14       Impact factor: 6.809

Review 3.  Antibody variable region glycosylation: biochemical and clinical effects.

Authors:  A Wright; S L Morrison
Journal:  Springer Semin Immunopathol       Date:  1993

Review 4.  Engineering the variable region of therapeutic IgG antibodies.

Authors:  Tomoyuki Igawa; Hiroyuki Tsunoda; Taichi Kuramochi; Zenjiro Sampei; Shinya Ishii; Kunihiro Hattori
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

Review 5.  The importance of oligosaccharides to rheumatic disease: a personal perspective.

Authors:  J S Axford
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

Review 6.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

Review 7.  Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire.

Authors:  Jens O Watzlawik; Bharath Wootla; Meghan M Painter; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2013-09       Impact factor: 4.618

8.  The V-region repertoire of Haemophilus influenzae type b polysaccharide antibodies induced by immunization of infants.

Authors:  G H Chung; K H Kim; R S Daum; R A Insel; G R Siber; S Sood; R K Gupta; C Marchant; M H Nahm
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 9.  Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

Authors:  Michaela Seeling; Christin Brückner; Falk Nimmerjahn
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

10.  Asparagine-linked oligosaccharides present on a non-consensus amino acid sequence in the CH1 domain of human antibodies.

Authors:  John F Valliere-Douglass; Paul Kodama; Mirna Mujacic; Lowell J Brady; Wes Wang; Alison Wallace; Boxu Yan; Pranhitha Reddy; Michael J Treuheit; Alain Balland
Journal:  J Biol Chem       Date:  2009-09-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.